Atrás
Precio Northstar Global Business Services Inc (MDIN)
Gráfico del Precio de Acciones MDIN
MDIN Ganando
Northstar Global Business Services Inc
$0
0%
$0
Al cierre: Feb 06, 16:00:00 GMT-5
$0
0%
$0
Mercado Posterior: Feb 06, 20:00:00 GMT-5
Sin datos aúnEarnings FAQ
¿Cómo se comparó el EPS reciente de MDIN con las expectativas?
¿Cómo fue el desempeño de los ingresos de Northstar Global Business Services Inc MDIN en el último trimestre?
¿Cuál es la estimación de ingresos para Northstar Global Business Services Inc?
¿Cuál es la puntuación de calidad de ganancias de Northstar Global Business Services Inc?
¿Cuándo informa Northstar Global Business Services Inc sus ganancias?
¿Cuáles son las ganancias esperadas de Northstar Global Business Services Inc?
¿Superó Northstar Global Business Services Inc las expectativas de ganancias?
Estadísticas clave
Cierre Anterior
$0
Precio de apertura
$0
Rango del día
$0 - $0
Rango de 52 semanas
$0 - $0
Volumen
33.3K
Volumen promedio
0
EPS (TTM)
0.00
Rendimiento de dividendos
--
Cap. de mercado
$1.0K
¿Qué es MDIN?
MedGen, Inc. engages in the manufacture, sale, and licensing of healthcare products. The company is headquartered in Boca Raton, Florida. The company went IPO on 2000-06-07. The firm's products are distributed via direct online sales, as well as retail distribution through its partners, and individual stores. Its products include SNORenz, SNORenz Night Time, Health Enrich for Pets, Stem-Intense and Wide Awake. The company others products include Sombium, Focamine and Relaxapro. SNORenz is a lubricating throat spray. SNORenz Night Time is also a lubricating throat spray and natural supplement sleep aid. Health Enrich for Pets is an anti-inflammatory and a catalyst that causes the body to be flooded with adult stem cells. Stem-Intense is a supplement for producing adult stem cells. Wide Awake is an energy spray and breath freshener. Sombium is a chemical-free sleep aid. Focamine is a concentration promoter. Relaxapro is an anti-anxiety medicine.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved